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Exposure of cultured diploid fibroblasts to protease solutions induces a hyperperrneable state 
which permits entry of exogenous macromolecules directly into the cytosol. We have exploited 
this finding to devise a microinjection method whose chief advantages are simplicity and good 
retention of cell viability. Proteins successfully injected by this technique range from insulin to 
thyroglobulin. The amounts injected range from 4 X 10’ to 5 X 10b molecules/cell. o 1988 
Academic Press. Inc. 
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Delineation of the loci and regulatory 
mechanisms ‘of cellular proteolysis is assisted 
by the direct introduction of a labeled pro- 
tein into the cytosolic compartment of cul- 
tured cells. A number of strategies have been 
devised to achieve this end. They have in 
common the production of transient defects 
in the plasma membrane, followed by entry 
of labeled protein into the cytosolic com- 
partment. Successful methods include eryth- 
rocyte ghost loading ( 1,2), hypotonic-os- 
motic lysis (3), scrape loading (4), detergent 
permeabilization (5), and electroporation 
(6). In our experience, all of the above lead to 
poor cell viability and/or small amounts of 
protein injected. In this paper we describe 
the technique of protease permeabilization 
of cultured fibroblasts. This method, which 
employs standard protease solutions used in 
passaging cells, permits introduction of la- 
beled protein directly into the cytosolic com- 
partment with cell viability after treatment 
equal to that of simple passaging. The proce- 
dure requires no special techniques or equip- 
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ment and appears superior to previously de- 
scribed methods. 
MATERIALS AND METHODS 
Diploid fibroblast cultures were derived 
from skin biopsies or necropsy material of 
patients with nephropathic cystinosis and 
maintained in Coon’+modified Ham’s Flz 
medium (GIBCO), supplemented with 15% 
(v/v) fetal bovine serum and incubated at 
37°C in a humidified incubator flushed with 
an air:COz ( 19: 1) mixture. DFL is a fetal lung 
fibroblast line from a cystinotic fetus. Con- 
trol normal fibroblasts (GM 0010) and cys- 
tinotic fibroblasts (GM 0090) were pur- 
chased from the Human Genetic Mutant 
Cell Repository. Cells were harvested by 
trypsin treatment and cell number deter- 
mined by a Model ZF Coulter counter 
(Coulter Instruments, Inc., Hialeah, FL). I?51 
was determined in a Tracer gamma counter. 
Counting efficiency for “‘I was 65%. “‘1 ly- 
sozyme (sp act, 2 19 pCi/mg) was a custom 
purchase from ICN; the other radiochemi- 
cals were purchased from New England Nu- 
clear. The specific activity of radiolabeled 
compounds was BSA,3 82.2 Ci/mmol: 
’ Abbreviations used: BSA, bovine serum albumin, 
5-IAF. S-iodoacetamide fluoresceine; SDS, sodium do- 
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insulin, 5 Ci/mg; thyroglobulin, 5.4 mCi/ 
mg; [‘4C]leucine. 348.3 mCi/mmol; and 
[3H]mannitol, 19.1 Ci/mmol. 
Pronase (activity, 87,110 puk/g) was pur- 
chased from Calbiochem-Behring Corp. Col- 
lagenase (207 u/g) was the product of 
Worthington Diagnostic Systems, Inc. ~-IO- 
doacetamide fluoresceine was purchased 
from Molecular Probes. 5-IAF-BSA was 
prepared as described (7). All other reagents 
were purchased from Sigma Chemical Co. 
SDS-polyacrylamide gel electrophoresis was 
performed by the method of Laemmli utiliz- 
ing a 4% stacking gel and a 10% analytical gel 
(8). Autoradiography was performed by ex- 
posing the dried gel to X-ray film at -70°C. 
MICROINJECTION PROCEDURE 
Confluent tissue culture plates of diploid 
fibroblasts were washed once with phos- 
phate-buffered saline, pH 7.4, containing 0.1 
g/liter calcium chloride, rinsed with trypsin 
(Difco 1:250, 2.5 g/liter in PBS with 0.201 
g/liter EDTA), and incubated at 37°C for 
approximately 5 min (the optimum time 
varied with cell line between 2 and 6 min). 
The cells were then detached from the dish 
by pipetting in 5 ml of Coon’s-modified 
Ham’s Fi2 medium supplemented with 15% 
fetal calf serum. The cells were removed 
from the Fiz medium by centrifugation for 4 
min at 600g. The pelleted cells were resus- 
pended in 1 ml of Flz without fetal calf 
serum, containing the protein to be injected, 
and after a gentle vortexing, incubated in 
suspension in a 37°C water bath for periods 
of time as described. At the end of the 37°C 
incubation the cells were collected by centrif- 
ugation at 600g for 4 min and then washed 
twice by vortexing in 10 ml of phosphate- 
buffered saline containing calcium chloride 
and 5 mg/ml of bovine serum albumin. After 
resuspension in Flz medium, an aliquot of 
decyl sulfate; PAGE, polyacrylamide gel electrophoresis; 
PBS, phosphate-buffered saline; PEG, polyethylene gly- 
col; IgG, immunoglobulin G. 
cells was removed for radioactivity and cell 
number determination, and the cells plated 
in culture dishes. Cell survival was deter- 
mined by retrypsinizing the cells after a 2-h 
period during which they were allowed to at- 
tach to the culture dish. The number of cells 
recovered at this point, divided by the num- 
ber of cells present after the initial exposure 
to trypsin for microinjection, was taken as a 
measure of cell viability. Line GM 00 10 was 
unusually sensitive to trypsin, with poor sur- 
vival after a standard 5-min exposure. Ex- 
periments using this line were routinely ex- 
posed to trypsin for only 2 min. 
Cells microinjected by permeabilization 
with pronase or collagenase were exposed to 
0.5 mg/ml collagenase in 0.25 M sucrose, 10 
mM Tris, pH 7.4, with 5 mM CaC12, or to 
0.025 mg/ml pronase in PBS. The optimal 
incubation period was 15-20 min for colla- 
genase and 2 min for pronase. After this vari- 
ation, the remainder of the microinjection 
procedure was as for trypsin. 
Unless otherwise specified, all microinjec- 
tion experiments described in this report 
used a standard 5-min exposure to trypsin 
followed by a 20-min incubation at 37°C for 
microinjection. To permit comparison be- 
tween experiments which employed differing 
concentrations of radioactivity, uptake is ex- 
pressed as the volume of medium whose 
contained substrate had been captured, per 
lo6 cells (pl/ lo6 cells) (9,lO). 
RESULTS 
After exposure to trypsin, fibroblasts be- 
come hyperpermeable to proteins in the me- 
dium in which they are suspended. In Fig. 1 
is shown the mean uptake of “‘1-BSA in 
three cells lines as a function of prior expo- 
sure to trypsin. After trypsin treatment for 
the indicated time, they are transferred to 
microinjection medium and incubated sus- 
pended in that medium for 20 min as de- 
scribed under Materials and Methods. Up- 
take increases after an initial lag period of 
about 2 to 3 min. At this point the cells have 
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FIG. 1. The erect of duration of incubation in trypsin 
on subsequent uptake of 12’I-BSA. Cells were incubated 
in trypsin as described under Materials and Methods and 
removed from the tissue culture dish at the intervals 
shown, after which they were suspended in medium 
containing 2 X IO6 cpm/ml of “‘1-BSA for 20 min. The 
cells were then washed twice with PBS containing 5 
mg/ml unlabeled BSA. and aliquots were removed for 
cell number and radioactivity determination. Cell lines 
were (A) GM 0090, (B) DFL, and (C) GM 0010. Error 
bars are means +l SD for (A) and (C); (B) shows the 
extremes of duplicate plates. 
begun to “round up” on the culture dish. 
Continued incubation in trypsin further en- 
hances uptake; however, cell viability de- 
clines after 7 min. For most cell lines, 4 to 5 
min in trypsin yielded the best compromise 
between uptake and viability. 
After a 5-min exposure to trypsin, resus- 
pended cells take up the labeled protein in 
the injection medium for 30 min (Fig. 2). 
Cell viability declined at longer periods of 
incubation; hence 20 min was selected as the 
best compromise between cell viability and 
injection. Enhanced uptake of 12%BSA is 
not limited to trypsin treatment alone. A 
similar increase in uptake was obtained after 
exposure of cultured cells to pronase and 
collagenase (see Fig. 2). Pronase (ex. Strepto- 
coccus griseus) is a proprietary product with 
wide protease activity. It rapidly detached fi- 
broblasts from the culture dish and led to cell 
death after more than 2 min of exposure. 
Collagenase had a much slower effect, with 
detachment not occurring until 15-20 min 
of incubation. 
To demonstrate that the protein is enter- 
ing directly into the cytosolic compartment 
and not merely binding to the cell surface or 
being pinocytosed at a greatly enhanced rate, 
trypsin-treated cells were exposed to culture 
medium containing 3 mg/ml of fluorescein- 
labeled albumin for 20 min, fixed in Kar- 
nofsky’s buffer, and examined by fluores- 
cence microscopy. Additional trypsin- 
treated cells were plated and fixed 2 h after 
reattachment. Non-trypsin-exposed control 
cells were fixed on the culture slide after a 
20-min exposure to fluorescein-BSA. In Fig. 
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FIG. 2. The effect of exposure to three proteases on the 
subsequent uptake of “‘1-BSA by cell line GM 0090. 
The cells were incubated in trypsin @I), pronase (Cl), or 
collagenase (+) as described under Materials and 
Methods. then washed and suspended in “51-BSA-con- 
taining medium, and harvested at the indicated times for 
cell count and radioactivity determination. 
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3A is shown the typical pattern of pinocytic 
vesicles resulting from pinocytosis of the flu- 
orescein-BS4 by attached cells during the 
20-min incubation. In contrast, Fig. 3B 
shows a difhisely fluorescent cytoplasm in 
the microinjected cells, consistent with per- 
meation of the fluorescent albumin into the 
cytosol. Twcl hours after microinjection, the 
cells have re.attached (C) but still retain dif- 
fuse fluorescence. 
The cytosolic localization of injected ma- 
terial was further verified by microinjecting 
‘251-lysozyme. Lysozyme has been shown to 
be preferentially degraded in the cytosol after 
conjugation to ubiquitin. Ubiquitination of 
lysozyme prior to degradation leads to a 
“ubiquitin ladder” on PAGE representing 
increasing molecular weight of the substrate 
as it is conjugated to multiple ubiquitin mol- 
ecules ( 1 l- 13). ‘251-lysozyme-injected cells 
were analyzed by SDS-polyacrylamide gel 
electrophoresis and autoradiography as 
shown in Fig. 4. In lane 2, a number of io- 
dinated species of molecular weight greater 
than that of the injected lysozyme are seen, 
consistent with polyubiquitination. One and 
four hours later, all the higher molecular 
weight forms are absent, and less lysozyme is 
present, presumably due to proteolysis (lanes 
3 and 4). No higher molecular weight forms 
are seen when the same medium is placed on 
cells not previously exposed to trypsin (lanes 
5-7). Since an equal number of cells is repre- 
sented in each lane ( 106), Fig. 4 also demon- 
strates the much greater uptake of protein by 
trypsin-treated cells (lanes 2-4) versus pino- 
cytosis (lanes 5-7). 
Known inhibitors of pinocytosis (NaCN, 
colchicine) ( 10,14) were found not to inhibit 
the uptake of “‘1-BSA after trypsin treat- 
ment, further supporting the contention that 
protease treatment results in cytosolic rather 
than pinocytic localization of the injected 
material (data not shown). 
A direct comparison of the amount of 
protein microinjected with that pinocytosed 
in the same interval was accomplished by 
parallel experiments in which the same me- 
dium was placed on tissue culture plates not 
exposed to trypsin and on trypsin-permeab- 
lized cells in suspension. In these experi- 
ments the mean uptake in 20 min of 12% 
BSA was 0.31 &million cells in line DFL 
after trypsin treatment, but only 0.04 &mil- 
lion cells in those not trypsin-treated. The 
corresponding values for trypsin versus non- 
trypsin-treated cells are 3.58 versus 0.32 in 
line GM 0090 and 1.48 versus 0.19 in line 
GM 0010. The difference between trypsin- 
treated and control cells in the uptake of BSA 
for all cell lines is significant at P = 0.02 by 
Student’s paired t test. There is significant 
line to line and day to day variation in the 
amount of ‘251-BSA taken up; however, in all 
lines the trypsin-treated cells took up 7 to 10 
times as much protein as the control cells. 
To ascertain if the cells were permeabilized 
to small molecules as well, the uptake of 
[3H]mannitol and [‘4C]leucine was mea- 
sured after trypsin treatment. Uptake of 
[ “C]leucine by trypsin-treated cells showed 
no saturation at concentrations of leucine of 
up to 20 mM (see Fig. 5). When [3H]manni- 
to1 uptake was studied, a rate of 0.20 t .07 
pl/’ 1 O6 cells/min was obtained. Previously es- 
tablished rates of uptake of membrane im- 
permeant solutes into substrate anchored 
cells are between 0.002 and 0.02 PI/ lo6 cells/ 
min ( 15). 
A number of fibroblast cell lines and pro- 
teins have been shown to be susceptible to 
this technique (Table 1). The mean uptake of 
“‘1-BSA in three fibroblast lines (GM 0090, 
GM 0010, and DFL) varied between 0.86 
FIG. 3. Fluorescent (A, B, C) photomicrographs of fibroblasts exposed to fluorescein-BSA for 20 min 
while substrate attached (A), following trypsinization (B), or 2 h after reattachment(C). Note pinosomes in 
attached spindle-shaped cells (A and C), as opposed to the diffuse cytoplasmic staining in spherical cells in 
suspension (B). After reattachment the cells regain the spindIe shape (C). Final magnification before 
photographic enlargement: (A) 650X; (B) and (C) 260X. 
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4 5 67 6 number of molecules per cell of each protein 
injected is also shown in Table 1. This num- 







FIG. 4. The fate of lysozyme microinjected by trypsin 
permeabilization compared to pinocytosed lysozyme. 
Cultures of GM 0010 were exposed to trypsin for 2 mitt, 
detached from the culture dish, and suspended in me- 
dium containing 2.98 X IO’ cpm/ml of %lysozyme at 
37°C for 20 min. The cells were then washed twice in 
PBS containing 5 mg/ml unlabeled lysozyme and plated. 
At 0 time and 1 and 4 h after plating. the cells were 
removed from culture, pelleted, and dissolved in run- 
ning buffer and an aliquot equal to lo6 cells was ana- 
lyzed by SDS-PAGE. The dried gel was then subjected 
to autoradiography as described under Materials and 
Methods. Control cells were identical except prior tryp- 
sin exposure was omitted. Lane 1, ‘“51-lysozyme me- 
dium. Lanes 2-4, cells preexposed to trypsin at 0, 1, and 
4 h after the incubation in suspension. Lanes 5-7, con- 
trols cells at 0, 1, and 4 h. Lane 8, molecular weight 
standards. A naturally occurring dimer is seen at M, 
28,000 in the initial medium and cells at all time points. 
and 1.98 &million cells in a 20-min injec- 
tion. The size of protein which can enter 
protease-permeabilized cells varied widely. 
As shown in Table 1, proteins taken up 
ranged from insulin (Mr 6000) to thyroglob- 
ulin (Mr 660,000). There was no apparent 
correlation between the amount taken up 
and the molecular weight of the protein. The 
Cell viability was assessed by harvesting 
cells after microinjection and attachment 
and comparing the number recovered to that 
present after initial trypsin treatment. In 15 
separate experiments employing three fibro- 
blast lines the mean survival expressed as 
above was 5 1 * 2.3%. This measure of viabil- 
ity, attachment, is similar to that found after 
simply passing the cell using typsin. A recent 
paper reported 54.4% attachment after tryp- 
sinization ( 16). 
DISCUSSION 
Of the many techniques currently avail- 
able for introducing exogenous macromole- 
cules into the cytoplasmic compartment of 
cultured cells, none appears to fulfill all the 
desirable criteria. Some (e.g., erythrocyte 
ghost fusion, direct microinjection, electro- 
poration) require large amounts of prepara- 
s WJ) 
FIG. 5. The uptake of [?Y]leucine into trypsin-treated 
cells in suspension. The cells were suspended in 1.0 ml 
medium containing [‘+‘C]leucine at a final concentration 
of 2.2 to 20.2 mM leucine and IOO-~1 aliquots taken at 
intervals of 0.5. 1. 2, 4. 6, and 8 min. The ahquot was 
immediately pipetted into 1 ml PBS at 4°C and centri- 
fuged. The pellet was washed once in PBS at 4°C and 
then dissolved in scintillation fluor for radioactivity de- 
termination. Duplicate aliquots were used for cell num- 
ber determination and the results expressed as nano- 
moles per lo6 cells for each interval. Initial rates were 
used to calculate the velocity of uptake. 
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TABLE 1 
PROTEASE-MEDIATED PROTEIN UPTAKE BY CULTURED FIBROBLASTS 
Amount injected 
A. Cell line (pi/ IO6 cells) 
GM 0090 0.86 3~ 0.36(n = 9) 
GM 0010 1.98 f  1.5 (n = 11) 
DFL 1.09 f  0.35 (n = 5) 
B. Protein WJ Molecules/cell 
insulin 6.000 0.97 5.84 x lo5 
Lysozyme 14,000 3.27 4.93 x IO6 
BSA 68,500 0.52 3.6 x lo5 
Thyroglobulin 660.000 2.98 1.8 x IO6 
Note. In part .4, the amount injected represents the mean fl SD of n experiments employing the standard 
exposure to trypsin and uptake of ‘251-BSA. In B, line GM 0010 was treated with trypsin and then exposed to the 
indicated proteins as under Materials and Methods. The data in part B are for single experiments with each protein. 
The concentrations of insulin, thyroglobulin, and BSA were each I.0 gM; lysozyme was 2.5 PM. 
tion and/or slpecial equipment. Others (e.g., 
scrape loading, hypotonic osmotic lysis) 
yield poor cell viability, load relatively small 
amounts of protein, or introduce only a re- 
stricted range of molecules (2). Erythrocyte 
ghost loading in a specialized cell line has 
been reported to deliver 1.8 X lo8 molecules 
of horseradish peroxidase per cell, and 1.4 
X lo7 molecules/cell of IgG (17). Scrape- 
loading has been reported to deliver lo7 dex- 
tran molecules/cell (18), whereas the delivery 
of BSA by erythrocyte ghosts is reported at 
2.7 X IO6 mollecules/cell, and that of IgG at 
2-5 X 105(1). 
Protease permeabilization of cultured fi- 
broblasts compares favorably with the above, 
allowing the injection of 10’ to lo6 mole- 
cules/cell (Table 1) of a variety of proteins 
directly into the cytosolic compartment. We 
have shown that the uptake of protein is into 
cytosol both by functional (Fig. 4) and mor- 
phologic (Fig. 3) criteria. The amount mi- 
croinjected corresponds to a captured vol- 
ume of medium of between 0.5 and 3.0 
&IO6 cells du.ring the standard 20-min in- 
cubation depending on the cell line, the pro- 
tein injected, and variation in the effect of 
the protease in producing channels in the 
plasma membrane. 
Uptake of leucine into cultured human fi- 
broblasts occurs primarily by System L, 
which has a Km of 0.1 mM and V,,,,x of about 
1.2 nmol/min/mg protein (19). From our 
data on the uptake of leucine by trypsin- 
treated fibroblasts in suspension (Fig. 5), it 
can be seen that uptake is nonsaturable to 
concentrations of 20 mM. At 20 mM the rate 
of uptake is calculated to be about 460 
nmol/min/mg protein.4 This is a rate almost 
400 times that of the V,,,,, for System L. Sim- 
ilarly, when the uptake of [3H]mannitol was 
studied, a rate of 10 to 100 times that of the 
normal pinocytosis rate was found (see Re- 
sults). These findings are most consistent 
with permeabilization of the plasma mem- 
brane. 
The large molecular weight range of pro- 
teins showing increased uptake after cells are 
trypsin permeabilized suggests that the pores 
formed after the procedure are larger than 
those produced by red blood cell ghost-me- 
diated microinjection. That procedure is lim- 
ited to molecules which can diffuse through 
pores of 20-50 nm (2). Since the red blood 
cell membrane is negatively charged, certain 
4 The cells used in these experiments contained 0.09 
f  0.03 mg protein/IO6 cells. 
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positively charged molecules adsorb strongly 
(e.g., lysozyme), limiting injection efficiency 
by this technique. Red blood cell fusion also 
alters the surface characteristics of the host 
cell by incorporating some of the red cell 
membranes into the host membrane. This, 
plus the effects of the fusogen (PEG, Sendai 
virus) may exert unpredictable effects on the 
host cell’s metabolism (2). 
With the scrape-loading technique, cells 
are physically detached from the culture dish 
with a rubber scraper and then transferred at 
4°C to medium containing the protein to be 
injected. The injected material presumably 
enters the cell via rents induced in the 
plasma membrane by the physical force 
which detaches the cells from the substrate. 
In our experience, cells subjected to this 
method do not reattach to the culture dish 
after injection and are essentially nonviable. 
Hypotonic-osmotic lysis is an ingenious 
technique which allows co-pinocytosis of hy- 
pertonic sucrose-containing medium to 
which has been added the protein to be 
loaded. After a brief period of uptake, the 
cells are exposed to hypotonic medium and 
the newly formed pinosomes rupture, releas- 
ing the labeled protein directly into the cyto- 
sol. This technique is limited by the rela- 
tively low rate of pinocytosis (2). Electropor- 
ation uses a brief electrical discharge to 
produce defects in the plasma membrane 
through which the protein is injected. We 
have been unable to obtain sufficient num- 
bers of viable cells to study proteolysis by this 
method. The same disadvantage applies to 
permeabilization of plasma membranes by 
detergents (for example, Brij 58). 
In contrast, cells are routinely passaged by 
exposure to trypsin or other proteases with 
excellent viability after such exposures. It is 
surprising that the hyperpermeability in- 
duced by such treatment apparently has not 
been previously recognized. Permeabiliza- 
tion by protease treatment could occur by 
simple degradation of transmembrane pro- 
teins, leaving channels through which the ex- 
ogenous protein can migrate. Alternatively, 
it has been shown that trypsin-treated cells 
round up, but remain attached to the culture 
dish by long cytoplasmic extensions termed 
“trypsinization retraction fib&” (20). It is 
possible that during detachment of trypsin- 
treated cells from the culture dish the termini 
of these extensions rupture, producing in ef- 
fect siphons which aspirate the culture me- 
dium. Physically this method may be analo- 
gous to scrape-loading, but detachment of 
the cells after protease treatment is gentler, 
leading to better cell viability. 
The implications of this finding are two- 
fold: (i) Cells are hyperpermeable after pas- 
saging and will take up significant amounts 
of molecules present in the culture medium 
in the postpassage period prior to attach- 
ment. (ii) All substrate-anchored cells sub- 
jected to electroporation are initially de- 
tached by protease treatment. It appears pos- 
sible that much of the injection attributed to 
electroporation is merely the result of incu- 
bating trypsin-permeabilized cells in suspen- 
sion. 
Recently, the study of cellular proteolysis 
has been markedly expanded by identifica- 
tion of a number of recognition sequences 
which permit selective proteolysis of specific 
proteins (2 1,22) and enhanced degradation 
of proteins under step-down conditions (23). 
Evidence has also been presented showing an 
apparent need for protein synthesis for lyso- 
somal proteolysis (24). Such studies require 
identification of a specific protein located in 
the cytosolic compartment to allow observa- 
tion of the regulation of catabolism (25,26). 
Protease-permeabilized microinjection ap- 
pears to confer significant advantages in 
achieving this goal. It requires no special 
equipment, yields excellent cell viability, and 
accomodates a broad range of injectable pro- 
teins. 
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